πŸ‡ΊπŸ‡Έ FDA
Patent

US 8455665

3-phenoxymethylpyrrolidine compounds

granted A61KA61K31/40A61K31/4025

Quick answer

US patent 8455665 (3-phenoxymethylpyrrolidine compounds) held by Theravance, Inc. expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/40, A61K31/4025, A61P, A61P13/00